Dwayne Wilson

Dwayne Wilson oversees the Good x Practice (GxP) Quality Management program at PATH, which ensures that quality guidelines and regulations are applied so that vaccine and drug products are safe, effective, and usable.

Based in Washington, DC, Mr. Wilson is a member of the Center for Vaccine Innovation and Access leadership team. Mr. Wilson oversees a global team of quality management professionals.

For more than two decades, Mr. Wilson has implemented clinical and commercial quality management systems, supporting products in the United States, Europe, Asia, and Africa.

Prior to joining PATH, he held roles in manufacturing, validation, quality control, and quality assurance. Mr. Wilson has experience with vaccine manufacturers, medical devices (Class I–III), cell therapy, diagnostic tools, and drugs. He has implemented robust quality systems that have resulted in successful regulatory inspections (in the United States, the European Union, and Asia) and product approvals. In addition to GxP system implementation, he also has experience implementing ISO 9001 and 13485 standards for quality management systems, leading to registration.